Novel topologically complex scaffold derived from alkaloid haemanthamine

Molecules

Volumn 23, Issue 2, 2018, Pages

  Govindaraju, Karthik ^a   Masi, Marco ^b   Colin, Margaux ^c   Mathieu, Veronique ^c   Evidente, Antonio ^b   Hudnall, Todd W ^a   Kornienko, Alexander ^a  

^a Texas State University   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Biological activity; Diversity oriented synthesis; Haemanthamine; Haemanthidine; Iodoalkoxylation; Natural product like

Indexed keywords

AMARYLLIDACEAE ALKALOID; HAEMANTHAMINE; PHENANTHRIDINE DERIVATIVE;

CHEMICAL STRUCTURE; CHEMISTRY;

AMARYLLIDACEAE ALKALOIDS; MOLECULAR STRUCTURE; PHENANTHRIDINES;

EID: 85041225146     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules23020255     Document Type: Article

References (21)

1. Newman, D.J.; Cragg, G.M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 2016, 79, 629-661. [CrossRef] [PubMed]
2. Galloway, W.R.; Isidro-Llobet, A.; Spring, D.R. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. Nat. Commun. 2010, 1, 80. [CrossRef] [PubMed]
3. Garcia-Castro, M.; Zimmerman, S.; Sankar, M.G.; Kumar, K. Scaffold diversity synthesis and its application in probe and drug discovery. Angew. Chem. Int. Ed. 2016, 55, 7586-7605. [CrossRef] [PubMed]
4. McLeod, M.C.; Singh, G.; Plampin, J.N., III; Rane, D.; Wang, J.L.; Day, V.W.; Aube, J. Probing chemical space with alkaloid-inspired libraries. Nat. Chem. 2014, 6, 133-140. [CrossRef] [PubMed]
5. Cui, J.; Hao, J.; Ulanovkaya, O.A.; Dundas, J.; Liang, J.; Kozmin, S.A. Creation and manipulation of common functional groups en route to a skeletally diverse chemical library. PNAS 2011, 108, 6763-6768. [CrossRef] [PubMed]
6. Borzilleri, R.M.; Vite, G.D. Case history: Discovery of ixabepilone (IXEMPRA?), a first-in-class epothilone analogue for treatment of metastatic breast cancer. Annu. Rep. Med. Chem. 2009, 44, 301-322.
7. Fasolo, A.; Sessa, C. Current and future directions in mammalian target of rapamycin inhibitor development. Expert Opin. Investig. Drugs. 2011, 20, 381-394. [CrossRef] [PubMed]
8. Morrison, K.C.; Hergenrother, P.J. Natural products as starting points for the synthesis of complex and diverse compounds. Nat. Prod. Rep. 2014, 31, 6-14. [CrossRef] [PubMed]
9. Pelish, H.E.; Westwood, N.J.; Feng, Y.; Kirchhausen, T.; Shair, M.D. Use of biomimetic diversity-oriented synthesis to discover galanthamine-like molecules with biological properties beyond those of natural product. J. Am. Chem. Soc. 2001, 123, 6740-6741. [CrossRef] [PubMed]
10. Kumar, N.; Kiuchi, M.; Tallarico, J.A.; Schreiber, S.L. Small-molecule diversity using a skeletal transformation strategy. Org. Lett. 2005, 7, 2535-2538. [CrossRef] [PubMed]
11. Balthaser, B.R.; Maloney, M.C.; Beeler, A.B.; Porco, J.A., Jr.; Snyder, J.K. Remodeling of the natural product fumagillol employing a reaction discovery approach. Nat. Chem. 2011, 3, 969-973. [CrossRef] [PubMed]
12. Appendino, G.C.; Tron, G.C.; Jarevang, T.; Sterner, O. Unnatural natural products from the transannular cyclization of lathyrane diterpenes. Org. Lett. 2001, 3, 1609-1612. [CrossRef] [PubMed]
13. de la Torre, M.C.; Garcia, I.; Sierra, M.A. Diversity oriented synthesis of hispanane-like terpene derivatives from (R)-(+)-scareolide. Chem. Eur. J. 2005, 11, 3659-3667. [CrossRef] [PubMed]
14. Kitayama, T.; Iwabuchi, R.; Minagawa, S.; Shiomi, F.; Cappiello, J.; Sawada, S.; Utsumi, R.; Okamoto, T. Unprecedented olefin-dependent histidine-kinase inhibitory of zerumbone ring-opening material. Bioorg. Med. Chem. Lett. 2004, 14, 5943-5946. [CrossRef] [PubMed]
15. Huisgens, R.W., III; Morrison, K.C.; Hicklin, R.W.; Flood, T.A., Jr.; Richter, M.F.; Hergenrother, P.J. A ring-distortion strategy to construct stereochemically complex and structurally diverse compounds from natural products. Nat. Chem. 2013, 5, 195-202. [CrossRef] [PubMed]
16. Van Goietsenoven, G.; Andolfi, A.; Lallemand, B.; Cimmino, A.; Lamoral-Theys, D.; Gras, T.; Abou-Donia, A.; Dubois, J.; Lefranc, F.; Mathieu, V.; et al. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells. J. Nat. Prod. 2010, 73, 1223-1227. [CrossRef] [PubMed]
17. Cedron, J.C.; Gutierrez, D.; Flores, N.; Ravelo, A.G.; Estevez-Braun, A. Synthesis and antimalarial activity of new haemanthamine-type derivatives. Bioorg. Med. Chem. 2012, 20, 5464-5472. [CrossRef] [PubMed]
18. Zhou, C.-Y.; Li, J.; Peddibholta, S.; Romo, D. Mild arming and derivatization of natural products via an In(OTf)3-catalyzed arene iodination. Org. Lett. 2010, 12, 2104-2107. [CrossRef] [PubMed]
19. Cedron, J.C.; Estevez-Braun, A.; Ravelo, A.G.; Guiterez, D.; Flores, N.; Bucio, M.A.; Perez-Hernandez, N.; Joseph-Nathan, P. Bioactivemontanine derivatives fromhalide-induced rearrangements of haemanthamine-type Alkaloids. Absolute configuration by VCD. Org. Lett. 2009, 11, 1491-1494. [CrossRef] [PubMed]
20. Inubushi, Y.; Fales, H.M.; Warnhoff, E.W.; Wildman, W.C. Structures of montanine, coccinine, and manthine. J. Org. Chem. 1960, 25, 2153-2164. [CrossRef]
21. Pellegrino, S.; Meyer, M.; Zorbas, C.; Bouchta, S.A.; Saraf, K.; Pelly, S.C.; Yusupova, G.; Evidente, A.; Mathieu, V.; Kornienko, A.; et al. The Amaryllidacae alkaloid haemanthamine binds the eukaryotic ribosome to repress cancer cell growh. Structure 2018, in press.